NewAmsterdam Pharma Company N.V. Warrant (NAMSW) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 62 116 sessions, October 23, 2025 to October 23, 2026
- Largest daily move
- +22.8% close of May 8, 2026
- 1-year change
- -62.1% closing prices, October 23, 2025 to October 23, 2026
- 1-month change
- -19.5% closing prices, September 22, 2026 to October 23, 2026
Company Description
NewAmsterdam Pharma Company N.V. Warrant (NASDAQ: NAMSW) is classified in the pharmaceutical preparations industry.
NAMSW has declined 62.1% over the past year. The last closing price was $9.25.
For FY2025, NewAmsterdam Pharma Company N.V. Warrant reported revenue of $22.5M with net income of -$203.8M and diluted earnings per share of -$1.72.
This page collects what Stock Titan holds for NAMSW, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) closed at $9.25 on October 23, 2026. Over the past 12 months, the price has lost 62.1%.
NAMSW Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NewAmsterdam Pharma Company N.V. Warrant has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, earnings. View all NAMSW news →
SEC Filings
NewAmsterdam Pharma Company N.V. Warrant has filed 10 recent SEC filings, including 5 Form 4, 2 Form 8-K, 1 Form 144, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on October 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NAMSW SEC filings →
Financial Highlights
NewAmsterdam Pharma Company N.V. Warrant generated $22.5M in revenue in FY2025, operating income reached -$225.7M, and net income was -$203.8M. Diluted earnings per share stood at -$1.72. The company generated -$147.8M in operating cash flow. The current ratio was 7.88, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in NewAmsterdam Pharma Company N.V. Warrant (NAMSW) currently stands at 42 shares, up 2.4% from the previous reporting period. Since October 2025, short interest has decreased by 98.4%.
Days to Cover History
Days to cover for NewAmsterdam Pharma Company N.V. Warrant (NAMSW) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has decreased by 87.5%. Across the settlements charted above, it has ranged from 1.0 to 8.0 days.
NAMSW Company Profile & Sector Positioning
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) and is listed on the NASDAQ.
Investors comparing NAMSW often look at related companies in the same sector, including Dermata Therapeutics, Inc. Warrant (DRMAW), Pasithea Therapeutics Corp. Warrants (KTTAW), Aspire-Lakewood Holdings, Inc. Warrant (ASBPW), Cingulate Inc. Warrants (CINGW), and Estrella Immunopharma, Inc. Warrant (ESLAW). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NAMSW's relative position within its industry.